|
||||
- Quitting Smoking and Zyban -
|
||||
Chantix has better statistics for abstinence from tobacco at one year. The percentages for continued abstinence reported in this study2 are still low, but appear to be better for those taking the quit smoking pill with varenicline.
- 10% for placebo
- 15% for buproprion
- 23% for varenicline
Some sources suggest that as a quit smoking pill Zyban dramatically reduces nicotine withdrawal symptoms and improves success at quitting.
Let's look at the numbers another way:
Nicotine withdrawal symptoms of a craving for a cigarette (this is the measurement of "wanting to smoke again") were found to be lower in the Zyban group by about 29%. This does appear to be dramatic.
However, the numbers for recidivism (starting smoking again) while statistically significant do not appear to be dramatic.
In the numbers here, the people who were quitting smoking with Zyban had only a 5% improvement at abstinence in one year than those people who took no stop smoking medication at all (placebo).
Zyban is not recommended as a stand alone stop smoking treatment and the data gathered from most studies included participants who were also in a stop smoking program that included education, counselling and psychological support.
Zyban affects brain chemistry.
There is no such thing as a risk free drug.
Some serious buproprion side effects have been reported. This is the active chemical in Zyban and Wellbutrin which is the antidepressant medication but essentially the same chemical.
Go from this information on Quitting Smoking and Zyban
to
Buproprion Side Effects
The recommended Zyban Dosage and instructions for using this stop smoking pill properly.
Inform yourself about
Prescription Drugs and Side Effects
How the Clinical Trial Data for Stop Smoking Medications is Determined
1.Tonnesen P et al(2003). A multicentre, randomized, double-blind, placebo-controlled, 1-year study of buproprion SR for smoking cessation". J Intern Med 254 (2): 184-192.
2. Jorenby D E et al(2006). Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release buproprion for smoking cessation: a randomized controlled trial". JAMA 296 (1): 56-63
Go back to Stop Smoking Pills
Using Chantix and the Drug Zyban to Control Nicotine Withdrawal Symptoms
Return to the Home Page: Smoking Facts Reveal
The Real Dangers of Cigarette Smoking
Copyright© 2012 www.smoking-facts-and-fiction.com All rights reserved.
home | about me | sitemap |disclosure
This website is a private commercial enterprise. Read the information about the owner and operator of this site.
The purpose of the information provided here is to help you cooperate with your doctor and other health practitioners. It is not intended to take the place of medical advice and you are encouraged to discuss health concerns with your physician or a professional health care provider who is familiar with you and your unique personal health context.
Return to top





